The Division of Infectious Disease at UT Southwestern Medical Center is dedicated to achieving the highest quality patient care, clinical and basic science research, and post-doctoral fellowship training in infectious disease.

Patient Care and Clinical Innovation

Our faculty are recognized authorities in the diagnosis and treatment of HIV/AIDS, hepatitis, meningitis, osteomyelitis, and other infectious conditions. We also offer experienced subspecialty care for patients in Parkland Memorial Hospital's burn recovery unit and the UT Southwestern transplant programs. Our Division also aims to develop and implement innovative practice models, such as our Outpatient Parenteral Antimicrobial Therapy Clinic, designed to fit the changing needs of patients and physicians in the field.

Research in Basic and Clinical Sciences

Our faculty perform cutting-edge clinical, translational, and basic science research in an outstanding research environment at UT Southwestern. Research within the Division of Infectious Disease has emphasized the pathogenesis and treatment of HIV, hepatitis C, and TB. We also offer research expertise in infectious disease epidemiology, correctional health, infection prevention and control, central nervous system infections, respiratory tract infections, and musculoskeletal infections.

Postdoctoral Training and Education

We offer a rigorous fellowship training program dedicated to producing academic physicians of exceptional caliber that combines extensive training in the management of a wide variety of infectious diseases with in-depth, mentored research training in the clinical or basic sciences. Our award-winning faculty also oversee an Ambulatory Infectious Diseases and Inpatient Infectious Disease curriculum for resident trainees.

In The News

Magnetic fields turn up the heat on bacterial biofilms

Magnetic fields turn up the heat on bacterial biofilms

August 08, 2017 – A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests.